Adipose-derived stem cells used to treat lymphedema in successful Phase I trial

Written by Harriet Wall

In a new Phase I clinical trial, scientists from Odense University Hospital (Denmark) have shown that adipose-derived stem cells could be used to treat lymphedema – a chronic condition that typically causes swelling in the arms or legs. This novel regenerative therapy could lead to a new avenue of treatment for patients with breast cancer-related lymphedema (BRCL). The results of the trial have been published in the journal STEM CELLS Translational Medicine. One in three women treated for breast cancer develop lymphedema, where fluid builds up in the lymph nodes – leading to painful swelling in these vessels. “Patients with BCRL...

To view this content, please register now for access

It's completely free